G-Protein Coupled Receptor

How GPCRs Work

G-protein coupled receptors span the cell membrane seven times (hence “seven transmembrane” or 7TM receptors). When activated, they initiate a cascade of intracellular signals:

1. Ligand binding - A peptide or hormone binds to the extracellular domain
2. Conformational change - The receptor changes shape, affecting its intracellular domains
3. G-protein activation - The receptor activates associated G-proteins by exchanging GDP for GTP
4. Effector activation - Activated G-proteins stimulate or inhibit enzymes (adenylyl cyclase, phospholipase C)
5. Second messenger production - These enzymes produce cAMP, calcium release, or other signals
6. Cellular response - Downstream effects on gene expression, metabolism, secretion

Types of G-Proteins

Different G-protein types produce different cellular effects:

G-protein	Effect on Second Messengers	Cellular Outcome
Gs (stimulatory)	Increases cAMP	Activation (insulin secretion, lipolysis)
Gi (inhibitory)	Decreases cAMP	Inhibition of secretion
Gq	Increases IP3 and calcium	Muscle contraction, secretion
G12/13	Activates Rho GTPases	Cytoskeleton changes

GPCRs in Peptide Research

Many therapeutic peptides act through GPCRs:

GLP-1 Receptor (GLP1R)

• Type: Class B GPCR
• Peptides: Semaglutide, tirzepatide, liraglutide
• G-protein: Primarily Gs
• Effect: cAMP increase leading to insulin secretion and appetite reduction

GIP Receptor (GIPR)

• Type: Class B GPCR
• Peptides: Tirzepatide (dual agonist), retatrutide (triple agonist)
• G-protein: Primarily Gs
• Effect: Enhanced insulin secretion, metabolic regulation

Ghrelin Receptor (GHSR)

• Type: Class A GPCR
• Peptides: Ipamorelin, GHRP-6, MK-677
• G-protein: Gq
• Effect: Growth hormone release from pituitary

Melanocortin Receptors (MC4R)

• Type: Class A GPCR
• Peptides: PT-141, melanotan II
• G-protein: Gs
• Effect: Appetite regulation, sexual function

GPCR Structure

Extracellular Space
    ↓
[Peptide Binding Domain]
    ↓
═══════════════════════ Cell Membrane
 ║ ║ ║ ║ ║ ║ ║  ← 7 Transmembrane Helices
═══════════════════════
    ↓
[G-protein Coupling Domain]
    ↓
Intracellular Space

Why GPCRs Are Important Drug Targets

Advantage	Explanation
Accessibility	Located on cell surface, no need to enter cell
Amplification	One receptor activates many G-proteins
Specificity	Different subtypes in different tissues
Druggability	Well-characterized binding pockets
Track record	Proven success with many approved drugs

Receptor Desensitization

GPCRs can become less responsive with continued activation:

1. Phosphorylation - Kinases add phosphate groups to activated receptor
2. Arrestin binding - Beta-arrestin binds phosphorylated receptor
3. Internalization - Receptor removed from surface via endocytosis
4. Downregulation - Reduced receptor synthesis with chronic exposure

This explains why effects of some peptides may diminish over time.

Frequently Asked Questions

Why are so many drugs designed to target GPCRs?

GPCRs regulate almost every physiological process - heart rate, blood pressure, mood, appetite, pain. Their structure makes them accessible to drugs, and decades of research have provided tools to design effective GPCR-targeting compounds.

What’s the difference between Class A and Class B GPCRs?

Class A GPCRs (like ghrelin receptor) bind small molecules and small peptides. Class B GPCRs (like GLP-1 receptor) have larger extracellular domains that bind larger peptide hormones. Different classes require different drug design approaches.

Can one peptide activate multiple GPCRs?

Yes. This is the principle behind multi-agonist drugs. Tirzepatide activates both GLP-1 and GIP receptors. Retatrutide activates GLP-1, GIP, and glucagon receptors. Targeting multiple receptors can produce enhanced or complementary effects.